rs17603420

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001349206.2(LPIN1):​c.1713+1158G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.513 in 152,104 control chromosomes in the GnomAD database, including 21,930 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.51 ( 21930 hom., cov: 33)

Consequence

LPIN1
NM_001349206.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.877

Publications

3 publications found
Variant links:
Genes affected
LPIN1 (HGNC:13345): (lipin 1) This gene encodes a magnesium-ion-dependent phosphatidic acid phosphohydrolase enzyme that catalyzes the penultimate step in triglyceride synthesis including the dephosphorylation of phosphatidic acid to yield diacylglycerol. Expression of this gene is required for adipocyte differentiation and it also functions as a nuclear transcriptional coactivator with some peroxisome proliferator-activated receptors to modulate expression of other genes involved in lipid metabolism. Mutations in this gene are associated with metabolic syndrome, type 2 diabetes, acute recurrent rhabdomyolysis, and autosomal recessive acute recurrent myoglobinuria (ARARM). This gene is also a candidate for several human lipodystrophy syndromes. [provided by RefSeq, Mar 2017]
LPIN1 Gene-Disease associations (from GenCC):
  • myoglobinuria, acute recurrent, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
  • hereditary recurrent myoglobinuria
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.743 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001349206.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LPIN1
NM_001349206.2
MANE Select
c.1713+1158G>A
intron
N/ANP_001336135.1Q14693-3
LPIN1
NM_001261428.3
c.1860+1158G>A
intron
N/ANP_001248357.1Q14693-7
LPIN1
NM_001349207.2
c.1803+1158G>A
intron
N/ANP_001336136.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LPIN1
ENST00000674199.1
MANE Select
c.1713+1158G>A
intron
N/AENSP00000501331.1Q14693-3
LPIN1
ENST00000256720.6
TSL:1
c.1605+1158G>A
intron
N/AENSP00000256720.2Q14693-1
LPIN1
ENST00000404113.6
TSL:1
n.1198+1158G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.513
AC:
77945
AN:
151986
Hom.:
21891
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.749
Gnomad AMI
AF:
0.426
Gnomad AMR
AF:
0.389
Gnomad ASJ
AF:
0.373
Gnomad EAS
AF:
0.214
Gnomad SAS
AF:
0.347
Gnomad FIN
AF:
0.505
Gnomad MID
AF:
0.335
Gnomad NFE
AF:
0.443
Gnomad OTH
AF:
0.457
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.513
AC:
78034
AN:
152104
Hom.:
21930
Cov.:
33
AF XY:
0.507
AC XY:
37711
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.750
AC:
31122
AN:
41516
American (AMR)
AF:
0.389
AC:
5936
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.373
AC:
1296
AN:
3472
East Asian (EAS)
AF:
0.214
AC:
1110
AN:
5176
South Asian (SAS)
AF:
0.347
AC:
1669
AN:
4814
European-Finnish (FIN)
AF:
0.505
AC:
5344
AN:
10576
Middle Eastern (MID)
AF:
0.337
AC:
99
AN:
294
European-Non Finnish (NFE)
AF:
0.443
AC:
30118
AN:
67964
Other (OTH)
AF:
0.451
AC:
952
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1814
3628
5443
7257
9071
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
652
1304
1956
2608
3260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.479
Hom.:
30772
Bravo
AF:
0.514
Asia WGS
AF:
0.275
AC:
959
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
0.032
DANN
Benign
0.40
PhyloP100
-0.88
RBP_binding_hub_radar
0.85
RBP_regulation_power_radar
1.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17603420; hg19: chr2-11929740; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.